• Aucun résultat trouvé

Correction to: Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials

N/A
N/A
Protected

Academic year: 2021

Partager "Correction to: Efficacy of phloroglucinol for the treatment of pain of gynaecologic or obstetrical origin: a systematic review of literature of randomised controlled trials"

Copied!
1
0
0

Texte intégral

(1)

CORRECTION

Correction to: Efficacy of phloroglucinol for the treatment of pain

of gynaecologic or obstetrical origin: a systematic review of literature

of randomised controlled trials

Clara Blanchard

1 &

Paul Vanderkam

1,2,3&

Denis Pouchain

4&

Stéphanie Mignot

1&

Hélène Vaillant-Roussel

5&

Rémy Boussageon

6

Published online: 23 November 2019

# Springer-Verlag GmbH Germany, part of Springer Nature 2019

Correction to: European Journal of Clinical Pharmacology

https://doi.org/10.1007/s00228-019-02745-7

The correct presentation of the Author names are shown in

this paper.

The online version of the original article can be found at https://doi.org/ 10.1007/s00228-019-02745-7

* Clara Blanchard

Cla.blanchard@gmail.com

1

Department of General Medicine, University of Poitiers, 6 rue de la Milétrie, TSA 51115, 86073 Poitiers Cedex 9, France

2

Clinical Research Unit, Henri Laborit Hospital, 370 avenue Jacques Coeur, CS 10587, 86021 Poitiers, France

3 Laboratory of Experimental and Clinical Neurosciences, University

of Poitiers, INSERM, U-1084, Poitiers, France

4

Department of General Medicine, University of Tours, 10 boulevard Tonnelé, 37032 Tours Cedex 1, France

5

Department of General Medicine and UPU ACCePPT, University of Auvergne, 18 place Henri Dunant, BP 38,

63001 Clermont-Ferrand, France

6 College of General Medicine, University of Lyon, 8 avenue

Rockfeller, 69373 Lyon Cedex 08, France European Journal of Clinical Pharmacology(2020) 76: https://doi.org/10.1007/s00228-019-02793-z

Références

Documents relatifs

following: (i) quality of trial (allocation concealment, completeness of follow-up, and blinding); (ii) age (<2 years or >2 years); (iii) perforated tympanic membrane (yes

enrolled populations, clinical trial design, and endpoints assessed vary greatly between studies. This variability is intuitive but its quantification is of importance because, as

Methods and Findings: This meta-analysis of randomised controlled trials evaluated metformin efficacy (in studies of metformin versus diet alone, versus placebo, and versus

3.. characterized by three factors: intensity of involvement, breadth of services spanned, and long-term commitment. Thus, there are two reasons to monitor consequences of

While two studies showed an increased reduction in the degree of overweight in the parent-only groups compared with parent – child and child-only interventions, the other four

COMET: Core Outcome Measures in Effectiveness Trials Initiative; ECRIN: European Clinical Research Infrastructure Network; ECRIN-IA: ECRIN- Integrating Activity; HTA: health

Their study in rats showed a hepatoprotective effect: Aronia nectar (fruit juice and pulp from the black chokeberry) inhibited nitrosamine production induced by aminopyrin and sodium

Similar to our sys- tematic reviews of osteoarthritis 8 and chronic low back pain, 9 we included only randomized controlled trials (RCTs) that reported a responder